K091741

Substantially Equivalent

TINA-QUANT CERULOPLASMIN

Applicant
Roche Diagnostics
Product code
CHN
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.